Longer Time to Chemotherapy Linked to Worse Outcomes in Triple-Negative Disease

7:07
 
Share
 

Manage episode 223016058 series 1013829
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.
Dr. Zaida Morante, medical oncologist at Instituto Nacional de Enfermedades Neoplásicas in Lima, Peru, explains her research that found delaying chemotherapy for more than 30 days was associated with worse outcomes in women diagnosed with early-stage, triple-negative breast cancer. Triple-negative breast cancer is breast cancer that is estrogen-receptor-negative, progesterone-receptor-negative, and HER2-negative. Listen to the podcast to hear Dr. Morante explain: the design of the study which outcomes delaying chemotherapy affected possible explanations for why chemotherapy was delayed for some women Running time: 7:07

127 episodes available. A new episode about every 8 days averaging 15 mins duration .